Pelthos Therapeutics Inc.
PTHS
$25.70
$0.562.23%
AMEX
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | 378.05% | 164.95% | |||
| Gross Profit | 1,060.57% | -164.95% | |||
| SG&A Expenses | 622.79% | 65.62% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 604.80% | 76.14% | |||
| Operating Income | -375.54% | -76.14% | |||
| Income Before Tax | -384.30% | -75.28% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -370.82% | -75.28% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -370.82% | -75.28% | |||
| EBIT | -375.54% | -76.14% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 1.50% | -67.70% | |||
| Normalized Basic EPS | -1.32% | -67.70% | |||
| EPS Diluted | 1.50% | -67.70% | |||
| Normalized Diluted EPS | -1.32% | -67.70% | |||
| Average Basic Shares Outstanding | 377.99% | 4.52% | |||
| Average Diluted Shares Outstanding | 377.99% | 4.52% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||